Human Lymphoid and Myeloid Cell Development in NOD/LtSz-scid IL2Rγnull Mice Engrafted with Mobilized Human Hemopoietic Stem Cells 12
By L. Shultz, B. Lyons, Lisa M. Burzenski, B. Gott, Xiaohua Chen, S. Chaleff, Malak Kotb, S. Gillies, Marie A. King, Julie Mangada and 2 more. Journal of Immunology, 2004
1,793 citations recorded by the source corpus.
Subfields: Immunology
View Paper: https://www.semanticscholar.org/paper/33ab1b58cf34068e285d23da67584f71d18ba833
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology
Citations in the corpus
- Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized (2010, background): “…30 years of research has found that the preferred system for studying the potential of normal human hematopoietic stem cells (Ito et al., 2002; Shultz et al., 2005) and human leukemic stem cells (Agliano et al., 2008; Sanchez et al., 2009) is NSG mice that are not only highly…”
- Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood. (2007, background): “Recently, the NOD/SCID/IL-2R null strain (NOG) strain was shown to exhibit significantly higher engraftment potential than other immunodeficient mouse strains when transplanted with human hematopoietic progenitors (Shultz et al., 2005).”
- Interluekin-12 enhances the function and anti-tumor activity in murine and human CD8+ T cells (2015, methodology): “1 3 Human T cells were cultured with or without hIL-12 during the entire length of the culture and then harvested for phenotypic analysis and subsequently injected in vivo into immunodeficient NSG mice [43].”